Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$4.6M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$233M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Lefebvre Eric | Jul 10, 2024 | Sell | 12,319 | $11.56 | $140,000 |
| Cummings Keith Lamont | Jul 10, 2024 | Sell | 10,911 | $11.56 | $130,000 |
| Coulie Bernard | Jul 10, 2024 | Sell | 38,710 | $11.56 | $450,000 |
| Hull Hans | Jul 10, 2024 | Sell | 9,900 | $11.56 | $110,000 |
| Ouimette Mike | Jul 10, 2024 | Sell | 7,656 | $11.56 | $89,000 |
| Coulie Bernard | Jan 17, 2024 | Sell | 25,721 | $17.23 | $440,000 |
| Lefebvre Eric | Jan 17, 2024 | Sell | 10,295 | $17.23 | $180,000 |
| Cummings Keith Lamont | Jan 17, 2024 | Sell | 9,781 | $17.23 | $170,000 |
| Hull Hans | Jan 17, 2024 | Sell | 9,786 | $17.23 | $170,000 |
| Ouimette Mike | Jan 17, 2024 | Sell | 5,197 | $17.23 | $90,000 |
| Hull Hans | Aug 4, 2023 | Sell | 20,050 | $20.01 | $400,000 |
| Hull Hans | Aug 3, 2023 | Sell | 13,069 | $20 | $260,000 |
| Hull Hans | Aug 3, 2023 | Sell | 1,800 | $20 | $36,000 |
| Ouimette Mike | Jul 20, 2023 | Sell | 4,755 | $17.55 | $83,000 |
| Ouimette Mike | Jul 17, 2023 | Sell | 12,778 | $18.0091 | $230,000 |
| Lefebvre Eric | Jul 17, 2023 | Sell | 22,321 | $18.0091 | $400,000 |
| Hull Hans | Jul 17, 2023 | Sell | 17,937 | $18.0091 | $320,000 |
| Cummings Keith Lamont | Jul 17, 2023 | Sell | 19,771 | $18.0091 | $360,000 |
| Coulie Bernard | Jul 17, 2023 | Sell | 70,150 | $18.0091 | $1.3M |
| Ouimette Mike | Apr 3, 2023 | Sell | 2,677 | $26.7371 | $72,000 |
| Ouimette Mike | Apr 3, 2023 | Sell | 200 | $27.455 | $5,500 |
| Lefebvre Eric | Mar 30, 2023 | Sell | 11,245 | $26.5209 | $300,000 |
| Coulie Bernard | Mar 30, 2023 | Sell | 35,339 | $26.5209 | $940,000 |
| Ouimette Mike | Mar 30, 2023 | Sell | 4,874 | $26.5209 | $130,000 |
| Hull Hans | Mar 30, 2023 | Sell | 9,036 | $26.5209 | $240,000 |
| Cummings Keith Lamont | Mar 30, 2023 | Sell | 9,960 | $26.5209 | $260,000 |
| Coulie Bernard | Feb 3, 2023 | Sell | 9,738 | $33.3629 | $320,000 |
| Coulie Bernard | Feb 3, 2023 | Sell | 5,262 | $34.0768 | $180,000 |
| Coulie Bernard | Feb 2, 2023 | Sell | 13,395 | $34.1265 | $460,000 |
| Coulie Bernard | Feb 2, 2023 | Sell | 1,605 | $34.9566 | $56,000 |
| Coulie Bernard | Feb 1, 2023 | Sell | 9,455 | $34.145 | $320,000 |
| Coulie Bernard | Feb 1, 2023 | Sell | 5,440 | $34.778 | $190,000 |
| Coulie Bernard | Feb 1, 2023 | Sell | 105 | $35.5548 | $3,700 |
| Coulie Bernard | Jan 31, 2023 | Sell | 15,000 | $34.917 | $520,000 |
| Coulie Bernard | Jan 30, 2023 | Sell | 11,395 | $33.9778 | $390,000 |
| Coulie Bernard | Jan 30, 2023 | Sell | 3,605 | $34.657 | $120,000 |
| Coulie Bernard | Jan 27, 2023 | Sell | 9,779 | $35.0913 | $340,000 |
| Coulie Bernard | Jan 27, 2023 | Sell | 8,698 | $35.4157 | $310,000 |
| Coulie Bernard | Jan 27, 2023 | Sell | 6,302 | $36.0589 | $230,000 |
| Coulie Bernard | Jan 27, 2023 | Sell | 221 | $36.64 | $8,100 |
| Coulie Bernard | Jan 26, 2023 | Sell | 15,000 | $35.095 | $530,000 |
| Coulie Bernard | Jan 25, 2023 | Sell | 13,304 | $32.4006 | $430,000 |
| Coulie Bernard | Jan 25, 2023 | Sell | 1,696 | $33.2897 | $56,000 |
| Coulie Bernard | Jan 24, 2023 | Sell | 15,000 | $30.8926 | $460,000 |
| Coulie Bernard | Jan 23, 2023 | Sell | 10,150 | $33.7106 | $340,000 |
| Ouimette Mike | Jan 23, 2023 | Sell | 20,000 | $34.1939 | $680,000 |
| Lefebvre Eric | Jan 23, 2023 | Sell | 67,500 | $34.4834 | $2.3M |
| Cummings Keith Lamont | Jan 23, 2023 | Sell | 30,000 | $35 | $1.1M |
| Coulie Bernard | Jan 23, 2023 | Sell | 4,850 | $34.9288 | $170,000 |
| Coulie Bernard | Jan 9, 2023 | Sell | 5,000 | $19.1658 | $96,000 |
| Coulie Bernard | Jan 6, 2023 | Sell | 15,000 | $19.0389 | $290,000 |
| Coulie Bernard | Jan 4, 2023 | Sell | 15,000 | $19.0627 | $290,000 |
What's the latest insider transaction for Pliant Therapeutics?
The most recent insider transaction for Pliant Therapeutics was conducted by Lefebvre Eric, who sold 12,319 shares on July 10, 2024 at a price of $11.56 per share.
Which insider has sold the most PLRX stock over the last two years?
Coulie Bernard has sold the most PLRX stock in the last 2 years, with a total value of $9.2M.
What is the total value of insider transactions for Pliant Therapeutics (PLRX) in the last 2 years?
The total value of insider transactions for Pliant Therapeutics in the last 2 years is negative, amounting to -$17M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Pliant Therapeutics' market confidence?
Over the last 2 years, insider transactions for Pliant Therapeutics have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
